Advertisement
Invizyne Technologies Inc... (IZTC)
NASDAQ: IZTC
· Real-Time Price · USD
16.50
1.00 (6.45%)
At close: Feb 11, 2025, 3:59 PM
Company Description
Invizyne Technologies, Inc. operates as a synthetic biochemical company in the United States.
The company develops SimplePath, a platform that produces chemicals, including pharmaceuticals, fuels, materials, food additives, and novel compounds.
Its platform also comprises one or more module which consist of one or more enzymes that work together to perform a defined biocatalytic conversion.
The company was founded in 2014 and is headquartered in Monrovia, California.
Invizyne Technologies Inc. Common Stock
| Country | United States |
| IPO Date | Nov 13, 2024 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 29 |
| CEO | Michael Heltzen |
Advertisement
Contact Details
Address: 750 Royal Oaks Drive Monrovia, Nevada United States | |
| Website | https://www.invizyne.com |
Stock Details
| Ticker Symbol | IZTC |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0002010788 |
| CUSIP Number | n/a |
| ISIN Number | US4618741098 |
| Employer ID | 83-4550057 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Michael Heltzen | Chief Executive Officer |
| Dr. Paul Opgenorth Ph.D. | Co-Founder & Vice President of Development |
| Dr. Tyler Korman Ph.D. | Co-Founder & Vice President of Research |
| Dr. Zachary Karl Ph.D. | Vice President & Head of Business Development |
| Fouad Nawaz | Vice President of Finance |
| James U. Bowie Ph.D. | Founder & Independent Director |
| Lasse H. Gorlitz | Vice President of Communications |
| Michael Burns | Executive Vice President of Energy Transition |
| Mohammad Hayat J.D. | Co-Founder, Chairman of the Board & President |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 07, 2025 | 424B3 | Filing |
| Apr 02, 2025 | 8-K | Current Report |
| Apr 02, 2025 | 8-K | Current Report |
| Apr 01, 2025 | 424B3 | Filing |
| Mar 31, 2025 | 10-K | Annual Report |
| Mar 25, 2025 | 3 | Filing |
| Feb 21, 2025 | 8-K | Current Report |
| Feb 11, 2025 | 8-K | Current Report |
| Jan 21, 2025 | 4 | Filing |
| Nov 19, 2024 | 4 | Filing |